The combination of tumor necrosis factor α blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model

✍ Scribed by Martine Chabaud; Pierre Miossec

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 138 KB
• Volume: 44
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/1529-0131(200106)44:6<1293::aid-art221>3.0.co;2-t